FIELD: medicine. SUBSTANCE: method involves determining erythrocyte resistance to peroxidation hemolysis initiated by ferrous iron and autoblood hemolysate in women beginning from the sixteenth week of pregnancy period. Erythrocyte resistance time is less than 150 s 2-4 weeks before clinical gestosis manifestations like arterial hypertension, proteinuria and edemas become visible. The value being greater than 150 s, pregnancy gestosis is predicted not to take place. EFFECT: high accuracy and simplicity of prognosis method.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING THE DEVELOPMENT OF GESTOSIS | 2005 |
|
RU2304783C1 |
| METHOD FOR PREDICTION OF THE RISK OF DEVELOPING SEVERE COMPLICATIONS OF PREECLAMPSIA | 2020 |
|
RU2741730C1 |
| METHOD FOR PREDICTING THE EFFECTIVENESS OF THE TREATMENT OF MODERATE PREECLAMPSIA | 2019 |
|
RU2705374C1 |
| METHOD FOR PREDICTING TOXAEMIAS OF PREGNANCY | 2014 |
|
RU2553624C1 |
| METHOD FOR PREDICTING CEREBRAL ISCHEMIA IN NEWBORNS BORN TO MOTHERS WITH PREECLAMPSIA | 2021 |
|
RU2777225C1 |
| METHOD FOR FORECASTING SEVERITY OF EARLY PREECLAMPSY | 2021 |
|
RU2753463C1 |
| METHOD OF DETERMINING EFFICIENCY OF IMMUNOCYTOTHERAPY IN PATIENTS WITH OPERABLE TOXEMIA OF PREGNANCY | 1996 |
|
RU2105311C1 |
| METHOD FOR EVALUATING PREECLAMPSIA SEVERITY IN PREGNANT WOMEN | 2003 |
|
RU2250468C2 |
| METHOD FOR PREDICTING GESTOSIS | 2005 |
|
RU2287823C1 |
| METHOD FOR PREDICTING EFFECTIVENESS OF TREATMENT OF MODERATE PREECLAMPSIA | 2020 |
|
RU2752715C1 |
